Leaflet FLUDARABINA TEVA 25mg / ml powder for solution for injection / infusion

Product code:
W64515001
Quantity:
1
Indicated for:
cancer
Route of administration:
injectable / infusion
Substance:
fludarabine (antimetabolite antineoplastic)
ATC
L01BB05 — Antineoplastic and immunomodulating agents | Antimetabolites | Purine analogues

Precautions:

Fertility warning

Fertility warning

This medicine may affect fertility.

Dose adjustment in hepatic impairment

Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Cytotoxic / special handling

Cytotoxic / special handling

Handle with special care.

Contraception required

Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding

Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hepatotoxicity

Hepatotoxicity

This medicine may affect the liver.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis

Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions

Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.


Fludarabine is a medication used to treat certain types of blood cancer, especially chronic lymphocytic leukemia. This medicine works by inhibiting the growth and multiplication of cancer cells, helping to control the disease and prolong patient survival. Fludarabine is often used when other treatments have not been successful or are not suitable for the patient.

Fludarabine is usually administered by intravenous infusion under the strict supervision of medical staff. The dose and duration of treatment are determined by the doctor based on the patient's general condition, type, and stage of the disease. It is essential to follow the treatment as directed to achieve the best results.

Side effects of fludarabine may include a decrease in blood cell counts, which increases the risk of infections, bleeding, or severe fatigue. Other reactions may include nausea, vomiting, diarrhea, or skin rashes. In rare cases, severe reactions such as nervous system damage or serious allergic reactions may occur.

Fludarabine is a powerful medication, and its administration requires careful monitoring and regular tests. Inform your doctor about any unusual symptoms or other medications you are taking. Following medical recommendations is essential for the safety and effectiveness of the treatment.

General data about FLUDARABINA TEVA 25mg / ml

Substance:
fludarabine
Date of latest medicines list:
01-06-2026
Product code:
W64515001
Concentration:
25mg / ml
Pharmaceutical form:
powder for solution for injection / infusion
Quantity:
1
Product type:
Generic medicine
Price:
179.92 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SINDAN PHARMA S.R.L. - ROMANIA
Holder:
TEVA B.V. - OLANDA
Number:
11989/2019/01
Shelf life:
4 years

Concentrations available for fludarabine

  • 10mg
  • 25mg/ml
  • 50mg

Compensation lists for FLUDARABINA TEVA 25mg / ml Teva

NHP 3 (C2) - NHP oncology

Price
179.92 RON
Copayment
179.92 RON
Patient
0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price
179.92 RON
Copayment
179.92 RON
Patient
0.00 RON